Treatment of childhood anxiety disorders: what is the place for antidepressants?

Bibliography

• Costello EJ, Mustillo S, Erkanli A, Prevalence and development of psychiatric disorders in childhood and adolescence. Arch Gen Psychiatry 2003;60:837-44
   PubMed Web of Science ®Google Scholar
• Costello EJ, Egger HL, Angold A. Developmental epidemiology of anxiety disorders. In: Ollendick TH, March JS, editors. Phobic and anxiety disorders in children and adolescents. A clinician's guide to effective psychosocial and pharmacological interventions. Oxford University Press; New York: 2004. p. 61-91
   Google Scholar
• Rapee RM, Schniering CA, Hudson JL. Anxiety disorders during childhood and adolescence: origins and treatment. Annu Rev Clin Psychol 2009;5:311-41
   PubMed Web of Science ®Google Scholar
• Kessler RC, Berglund P, Demler O, Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the national comorbidity survey replication. Arch Gen Psychiatry 2005;62:593-602
   PubMed Web of Science ®Google Scholar
• Muris P. Normal and abnormal fear and anxiety in children and adolescents. Elsevier; Oxford: 2007
   Google Scholar
• Vasey MW, Dadds MR. The developmental psychopathology of anxiety. Oxford University Press; New York: 2001
   Google Scholar
• Eley TC, Gregory AM. Behavioral genetics. In: Morris TL, March JS, editors. Anxiety disorders in children and adolescents. Guilford Press; New York: 2004. p. 71-97
   Google Scholar
• Pine DS. Pathophysiology of childhood anxiety disorders. Biol Psychiatry 1999;46:1555-66
   PubMed Web of Science ®Google Scholar
• Pine DS. A neuroscience framework for pediatric anxiety disorders. J Child Psychol Psychiatry 2007;48:631-48
   PubMed Web of Science ®Google Scholar
• Muris P, Ollendick TH. The role of temperament in the etiology of child psychopathology. Clin Child Fam Psychol Rev 2005;8:271-89
   PubMed Web of Science ®Google Scholar
• Muris P, Field AP. Distorted cognition and pathological anxiety in children and adolescents. Cogn Emotion 2008;22:395-421
   Web of Science ®Google Scholar
• Bogels SM, Brechman-Toussaint ML. Family issues in child anxiety: attachment, family functioning, parental rearing, and beliefs. Clin Psychol Rev 2006;26:834-56
   PubMed Web of Science ®Google Scholar
• Ipser JC, Stein DJ, Hawkridge S, Hoppe L. Pharmacotherapy for anxiety disorders in children and adolescents. Cochrane Database Syst Rev 2009;3:CD005170
   Google Scholar
• Ollendick TH, King NJ. Empirically supported treatments for children with phobic and anxiety disorders: Current status. J Clin Child Psychol 1998;27:156-67
   PubMed Web of Science ®Google Scholar
• Bogels SM, Siqueland L. Family cognitive behavioral therapy for children and adolescents with clinical anxiety disorders. J Am Acad Child Adolesc Psychiatry 2006;45:134-41
   PubMed Web of Science ®Google Scholar
• American Academy of Child and Adolescent Psychiatry. Practice parameter for the assessment and treatment of children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2007;46:267-83
   PubMed Web of Science ®Google Scholar
• Nemeroff CB, Kalali A, Keller MB, Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Arch Gen Psychiatry 2007;64:466-72
   PubMed Web of Science ®Google Scholar
• Pandolfini C, Bonati M. A literature review on off-label drug use in children. Eur J Pediatr 2005;164:552-8
   PubMed Web of Science ®Google Scholar
• Marks IM. Fears, phobias, and rituals. Panic, anxiety, and their disorders. Oxford University Press; New York: 1987
   Google Scholar
• Beck AT, Emery G. Anxiety disorders and phobias: A cognitive perspective. Basic Book; New York: 1985
   Google Scholar
• Albano AM, Kendall PC. Cognitive behavioural therapy for children and adolescents with anxiety disorders: Clinical research advances. Int Rev Psychiatry 2002;14:129-34
   Web of Science ®Google Scholar
• Kendall PC. Treating anxiety disorders in children: results of a randomized clinical trial. J Consult Clin Psychol 1994;62:100-10
   PubMed Web of Science ®Google Scholar
• Cartwright-Hatton S, Roberts C, Chitsabesan P, Systematic review of the efficacy of cognitive behaviour therapies for childhood and adolescent anxiety disorders. Br J Clin Psychol 2004;43:421-36
   PubMed Web of Science ®Google Scholar
• In-Albon T, Schneider S. Psychotherapy of childhood anxiety disorders: a meta-analysis. Psychother Psychosom 2007;76:15-24
   PubMed Web of Science ®Google Scholar
• Kendall PC, Flannery-Schroeder E, Panicelli-Mindel S, Therapy for youths with anxiety disorders: A second randomized clinical trial. J Consult Clin Psychol 1997;65:366-80
   PubMed Web of Science ®Google Scholar
• Barrett PM, Duffy AL, Dadds MR, Rapee RM. Cognitive-behavioral treatment of anxiety disorders in children: Long-term (6-year) follow-up. J Consult Clin Psychol 2001;69:135-41
   PubMed Web of Science ®Google Scholar
• Kendall PC, Safford S, Flannery-Schroeder E, Webb A. Child anxiety treatment: Outcomes in adolescence and impact on substance use and depression at 7.4-year follow-up. J Consult Clin Psychol 2004;72:276-87
   PubMed Web of Science ®Google Scholar
• March JS, Mulle K. OCD in children and adolescents. A cognitive-behavioral treatment manual. Guilford; New York: 1998
   Google Scholar
• March JS, Amaya-Jackson L, Murray MC, Schulte A. Cognitive-behavioral psychotherapy for children and adolescents with posttraumatic stress disorder after a single-incident stressor. J Am Acad Child Adolesc Psychiatry 1998;37:585-93
   PubMed Web of Science ®Google Scholar
• Ollendick TH, Ost LG, Reuterskiold L, One-session treatment of specific phobias in youth: a randomized clinical trial in the United States and Sweden. J Consult Clin Psychol 2009;77:504-16
   PubMed Web of Science ®Google Scholar
• Flannery-Schroeder EC, Kendall PC. Group and individual cognitive-behavioral treatment for youth with anxiety disorders: A randomized clinical trial. Cogn Ther Res 2000;24:251-78
   Web of Science ®Google Scholar
• Manassis K, Mendlowitz SL, Scapillato D, Group and individual cognitive-behavioral therapy for childhood anxiety disorders: A randomized trial. J Am Acad Child Adolesc Psychiatry 2002;41:1423-30
   PubMed Web of Science ®Google Scholar
• Barrett PM, Dadds MR, Rapee RM. Family treatment of childhood anxiety: a controlled trial. J Consult Clin Psychol 1996;64:333-42
   PubMed Web of Science ®Google Scholar
• Shortt AL, Barrett PM, Fox TL. Evaluating the FRIENDS program: a cognitive-behavioral group treatment for anxious children and their parents. J Clin Child Adolesc Psychol 2001;30:525-35
   Google Scholar
• Barrett PM. Evaluation of cognitive-behavioral group treatments for childhood anxiety disorders. J Clin Child Psychol 1998;27:459-68
   PubMed Web of Science ®Google Scholar
• Mendlowitz SL, Manassis K, Bradley S, Cognitive-behavioral group treatments in childhood anxiety disorders: The role of parental involvement. J Am Acad Child Adolesc Psychiatry 1999;38:1223-9
   PubMed Web of Science ®Google Scholar
• Wood JJ, Piacentini JC, Southam-Gerow M, Family cognitive behavioral therapy for child anxiety disorders. J Am Acad Child Adolesc Psychiatry 2006;45:314-21
   PubMed Web of Science ®Google Scholar
• Cobham VE, Dadds MR, Spence SH. The role of parental anxiety in the treatment of childhood anxiety. J Consult Clin Psychol 1998;66:893-905
   PubMed Web of Science ®Google Scholar
• Southam-Gerow MA, Kendall PC, Weersing VR. Examining outcome variability: Correlates of treatment response in a child and adolescent anxiety clinic. J Clin Child Psychol 2001;30:422-36
   PubMed Web of Science ®Google Scholar
• Nauta MH, Scholing A, Emmelkamp P, Minderaa RB. Cognitive-behavioral therapy for children with anxiety disorders in a clinical setting: No additional effect of a cognitive parent training. J Am Acad Child Adolesc Psychiatry 2003;42:1270-8
   PubMed Web of Science ®Google Scholar
• Bodden D, Bogels SM, Nauta MH, Child versus family cognitive-behavioral therapy in clinically anxious youth: An efficacy and partial effectiveness study. J Am Acad Child Adolesc Psychiatry 2008;47:1384-94
   PubMed Web of Science ®Google Scholar
• Barmish AJ. Kendall PC. Should parents be co-clients in cognitive-behavioral therapy for anxious youth? J Clin Child Adolesc Psychol 2005;34:569-81
   PubMed Web of Science ®Google Scholar
• Southam-Gerow M, Kendall PC, Weersing VR. Examining outcome variability: Correlates of treatment response in a child and adolescent anxiety clinic. J Clin Child Psychol 2001;30:422-36
   PubMed Web of Science ®Google Scholar
• Berman SL, Weems CF, Silverman WK, Kurtiness WM. Predictors of outcome in exposure-based cognitive and behavioral treatments for phobic and anxiety disorders in children. Behav Ther 2000;31:713-31
   Web of Science ®Google Scholar
• Cohen J. A power primer. Psychol Bull 1992;112:155-9
   PubMed Web of Science ®Google Scholar
• Kodish I, Rockhill C, Ryan S, Varley C. Pharmacotherapy for anxiety disorders in children and adolescents. Pediatr Clin N Am 2011;58:55-72
   PubMed Web of Science ®Google Scholar
• Walkup JT, Labellarte MJ, Ginsburg GS. The pharmacological treatment of childhood anxiety disorders. Int Rev Psychiatry 2002;14:135-42
   Web of Science ®Google Scholar
• Graae F, Milner J, Rizzoto L, Klein RG. Clonazepam in childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 1994;33:372-6
   PubMed Web of Science ®Google Scholar
• Simeon JG, Ferguson HB, Knott V, Clinical, cognitive and neurophysiological effects of alprazolam in children and adolescents with overanxious and avoidant disorders. J Am Acad Child Adolesc Psychiatry 1992;31:29-33
   PubMed Web of Science ®Google Scholar
• Yanase H, Braham RL, Fukuta O, Kurosu K. A study of the sedative effect of home-administered oral diazepam for the dental treatment of children. Int J Paediatr Dent 1996;6:13-17
   PubMedGoogle Scholar
• Nelson JC. Tricyclic and tetracyclic drugs. In: Schatzberg AF, Nemeroff CB, editors. The American psychiatric publishing textbook of psychopharmacology. American Psychiatric Publishing; New York: 2009. p. 263-88
   Google Scholar
• Leonard HL, Swedo SE, Rapoport JL, Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison. Arch Gen Psychiatry 1989;46:1088-92
   PubMed Web of Science ®Google Scholar
• Flament MF, Rapoport JL, Berg CJ, Clomipramine treatment of childhood obsessive-compulsive disorder: A double-blind controlled study. Arch Gen Psychiatry 1985;42:977-83
   PubMed Web of Science ®Google Scholar
• DeVaugh-Geiss J, Moroz G, Biederman J, Clomipramine hydrochloride in childhood and adolescent obsessive-compulsive disorder. A multicenter trial. J Am Acad Child Adolesc Psychiatry 1992;31:45-9
   PubMedGoogle Scholar
• Goodman WK, Price LH, Rasmussen SA, The Yale-Brown Obsessive-Compulsive Scale (Y-BOCS): I. Development, use, and reliability. Arch Gen Psychiatry 1989;46:1006-11
   PubMed Web of Science ®Google Scholar
• De Haan E, Hoogduin KAL, Buitelaar JK, Keijsers GPJ. Behavior therapy versus clomipramine for the treatment of obsessive-compulsive disorder in children and adolescents. J Am Acad Child Adolesc Psychiatry 1998;37:1022-9
   PubMed Web of Science ®Google Scholar
• Gittelman-Klein R, Klein DF. Controlled imipramine treatment of school phobia. Arch Gen Psychiatry 1971;25:204-7
   Web of Science ®Google Scholar
• Klein RG, Koplewicz HS, Kanner A. Imipramine treatment of children with separation anxiety disorder. J Am Acad Child Adolesc Psychiatry 1992;31:21-8
   PubMed Web of Science ®Google Scholar
• Bernstein GA, Borchardt CM, Perwien AR, Imipramine plus cognitive-behavioral therapy in the treatment of school refusal. J Am Acad Child Adolesc Psychiatry 2000;39:276-83
   PubMed Web of Science ®Google Scholar
• Berney T, Kolvin I, Bhate SR, School phobia: a therapeutic trial with clomipramine and short-term outcome. Br J Psychiatry 1981;138:110-18
   PubMed Web of Science ®Google Scholar
• Riddle MA, Geller B, Ryan N. Case study: another sudden death in a child treated with desipramine. J Am Acad Child Adolesc Psychiatry 1993;32:792-7
   PubMed Web of Science ®Google Scholar
• Stahl SM. Stahl's essential psychopharmacology: neuroscientific basis and practical applications. Cambridge University Press; New York; 2008
   Google Scholar
• Riddle MA, Scahill L, King RA, Double-blind crossover trial of fluoxetine and placebo in children with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1992;31:1062-9
   PubMed Web of Science ®Google Scholar
• Geller DA, Hoog SL, Heiligenstein JH, Fluoxetine treatment for obsessive-compulsive disorder in children and adolescents: A placebo-controlled clinical trial. J Am Acad Child Adolesc Psychiatry 2001;40:773-9
   PubMed Web of Science ®Google Scholar
• Liebowitz MR, Turner SM, Piacentini J, Fluoxetine in children and adolescents with OCD: a placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2002;41:1431-8
   PubMed Web of Science ®Google Scholar
• Ashbar FR, Castillo AR, Ito LM, Group cognitive-behavioral therapy versus sertraline for the treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2005;44:1128-36
   PubMedGoogle Scholar
• Pediatric OCD Treatment Study (POTS) Team. Cognitive-behavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder. JAMA 2004;292:1969-76
   PubMed Web of Science ®Google Scholar
• March JS, Biederman J, Wolkow R, Sertraline in children and adolescents with obsessive-compulsive disorder. A multicenter randomized controlled trial. JAMA 1998;280:1752-6
   PubMed Web of Science ®Google Scholar
• Alaghband-Rad J, Hakimshooshtary M. A randomized controlled clinical trial of citalopram versus fluoxetine in children and adolescents with obsessive-compulsive disorder (OCD). Eur Child Adolesc Psychiatry 2009;18:131-5
   PubMed Web of Science ®Google Scholar
• Geller DA, Wagner KD, Emslie G, Paroxetine treatment in children and adolescents with obsessive-compulsive disorder: a randomized, multicenter, double-blind, placebo-controlled trial. J Am Acad Child Adolesc Psychiatry 2004;43:1387-96
   PubMed Web of Science ®Google Scholar
• Riddle MA, Reeve EA, Yaryura-Tobias JA, Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial. J Am Acad Child Adolesc Psychiatry 2001;49:222-9
   Google Scholar
• Black B, Uhde TW. Treatment of elective mutism with fluoxetine: a double-blind, placebo-controlled study. J Am Acad Child Adolesc Psychiatry 1994;33:1000-6
   PubMed Web of Science ®Google Scholar
• Birmaher B, Axelson DA, Monk K, Fluoxetine for the treatment of childhood anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003;42:415-23
   PubMed Web of Science ®Google Scholar
• Beidel DC, Turner SM, Sallee FR, SET-C versus fluoxetine in the treatment of childhood social phobia. J Am Acad Child Adolesc Psychiatry 2007;46:1622-32
   PubMed Web of Science ®Google Scholar
• RUPP Anxiety Study Group. Fluvoxamine for the treatment of anxiety disorders in children and adolescents. N Engl J Med 2001;344:1279-85
   PubMedGoogle Scholar
• Wagner KD, Berard R, Stein MB, A multi-center, randomized, double-blind, placebo-controlled trial of paroxetine in children and adolescents with social anxiety disorder. Arch Gen Psychiatry 2004;61:1153-62
   PubMed Web of Science ®Google Scholar
• Rynn MA, Siqueland L, Rickels K. Placebo-controlled trial of sertraline in the treatment of children with generalized anxiety disorder. Am J Psychiatry 2001;158:2008-14
   PubMed Web of Science ®Google Scholar
• Cohen JA, Mannarino AP, Perel JM, Staron V. A pilot randomized controlled trial of combined trauma-focused CBT and sertraline for childhood PTSD symptoms. J Am Acad Child Adolesc Psychiatry 2007;46:811-19
   PubMed Web of Science ®Google Scholar
• Robb AS, Cueva JE, Sporn J, Sertraline treatment of children and adolescents with posttraumatic stress disorder: a double-blind, placebo-controlled trial. J Child Adolesc Psychopharmacol 2010;20:463-70
   PubMed Web of Science ®Google Scholar
• Walkup JT, Albano AM, Piacentini J, Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. New Engl J Med 2008;359:2753-66
   PubMed Web of Science ®Google Scholar
• The research units on pediatric psychopharmacology anxiety study group. The Pediatric Anxiety Rating Scale (PARS): development and psychometric properties. J Am Acad Child Adolesc Psychiatry 2002;41:1061-9
   PubMed Web of Science ®Google Scholar
• Seidel L, Walkup JT. Selective serotonin reuptake inhibitor use in the treatment of the pediatric non-obsessive-compulsive disorder anxiety disorders. J Child Adolesc Psychopharmacol 2006;16:171-9
   PubMed Web of Science ®Google Scholar
• Bridge JA, Iyengar S, Salary CB, Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials. JAMA 2007;297:1683-96
   PubMed Web of Science ®Google Scholar
• Rynn MA, Riddle MA, Yeung PP, Kunz NR. Efficacy and safety of extended-release venlafaxine in the treatment of generalized anxiety disorder in children and adolescents: two placebo-controlled trials. Am J Psychiatry 2007;164:290-300
   PubMed Web of Science ®Google Scholar
• March JS, Entusah AR, Rynn M, A randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder. Biol Psychiatry 2007;62:1149-54
   PubMed Web of Science ®Google Scholar
• Pine DS. Treating children and adolescents with selective serotonin reuptake inhibitors: How long is appropriate? J Child Adolesc Psychopharmacol 2002;12:189-203
   PubMed Web of Science ®Google Scholar
• Clark DB, Birmaher B, Axelson D, Fluoxetine for the treatment of childhood anxiety disorders: open-label, long-term extension to a controlled trial. J Am Acad Child Adolesc Psychiatry 2005;44:1263-70
   PubMed Web of Science ®Google Scholar
• Wolfarth T, Kalverdijk L, Rademaker C, Psychopharmacology for children: From off-label use to registration. Eur Neuropsychopharmacol 2009;19:603-8
   PubMedGoogle Scholar
• Stein MB, Seedat S. Pharmacotherapy. In: Morris TL, March JS, editors. Anxiety disorders in children and adolescents. Guilford Press; New York: 2004. p. 329-54
   Google Scholar
• Waslick B. Psychopharmacology interventions for pediatric anxiety disorders: a research update. Child Adolesc Psychiatr Clin N Am 2006;15:51-71
   PubMedGoogle Scholar
• RUPP Anxiety Study Group. Searching for moderators and mediators of pharmacological treatment effects in children and adolescents with anxiety disorders. J Am Acad Child Adolesc Psychiatry 2003;42:13-21
   PubMedGoogle Scholar
• Brown AM, Deacon BJ, Abramowitz JS, Parents' perceptions of pharmacological and cognitive-behavioral treatments for childhood anxiety disorders. Behav Res Ther 2007;45:819-28
   PubMed Web of Science ®Google Scholar
• March JS, Ollendick TH. Integrated psychosocial and pharmacological treatment. In: Ollendick TH, March JS, editors. Phobic and anxiety disorders in children and adolescents. A clinician's guide to effective psychosocial and pharmacological interventions. Oxford University Press; New York: 2004. p. 141-72
   Google Scholar
• Pina AA, Silverman WK, Weems CF, A comparison of completers and noncompleters of exposure-based cognitive and behavioral treatment for phobic and anxiety disorders in youth. J Consult Clin Psychol 2003;71:701-5
   PubMed Web of Science ®Google Scholar
• Keeton CP, Ginsburg GS. Combining and sequencing medication and cognitive-behaviour therapy for childhood anxiety disorders. Int Rev Psychiatry 2008;20:159-64
   PubMed Web of Science ®Google Scholar
• King NJ, Muris P, Ollendick TH. Childhood fears and phobias: assessment and treatment. Child Adolesc Ment Health 2005;10:50-6
   PubMedGoogle Scholar
• Norrholm SD, Ouimet CC. Altered dendritic spine density in animal models of depression and in response to antidepressant treatment. Synapse 2001;42:151-63
   PubMed Web of Science ®Google Scholar
• Wegerer V, Moll GH, Bagli M, Persistently increased density of serotonin transporters in the frontal cortex of rats treated with fluoxetine during early juvenile life. J Child Adolesc Psychopharmacol 1999;9:13-24
   PubMed Web of Science ®Google Scholar